In 2021, the phenotypic spectrum of Syt1-associated neurodevelopmental disorder was expanded, upon identification of various novel pathogenic (or likely pathogenic) variants, including the ones in the C2A domain (Melland et al., 2022). The gene discussed is SYT1; the disease is neurodevelopmental disorder.